Top Banner
NoCVA Hospital Engagement Network CLABSI Collaborative Orientation Webinar #3 Learning from Defects August 28, 2012 Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety Virginia Hospital and Healthcare Association Shelby Lassiter, RN, BSN, CPHQ, CIC North Carolina Quality Center
46

Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Jan 14, 2016

Download

Documents

Cecile Cayanan

NoCVA Hospital Engagement Network CLABSI Collaborative Orientation Webinar #3 Learning from Defects August 28, 2012. Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety Virginia Hospital and Healthcare Association Shelby Lassiter, RN, BSN, CPHQ, CIC - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

NoCVA Hospital Engagement Network

CLABSI CollaborativeOrientation Webinar #3

Learning from DefectsAugust 28, 2012

Jan Mangun, MT(ASCP), MSA, CPHRMExecutive Director, Quality and Patient SafetyVirginia Hospital and Healthcare Association

Shelby Lassiter, RN, BSN, CPHQ, CICNorth Carolina Quality Center

Page 2: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Partnership for Patients Goals

• By the end of 2013, preventable hospital acquired conditions would be reduced by 40%, compared to 2010Adverse Drug Events CAUTICLABSI FallsOB Adverse Events Pressure UlcersSSI’s VTEVAP

• By the end of 2013, 30-day hospital readmissions would be reduced by 20%, compared to 2010

The CLABSI Collaborative is designed to impact the CLABSI Reduction P4P goal

2

Page 3: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Participants will be able to:1. Describe how defect analysis is a foundational element of

CUSP.

2. Define “defect.”

3. Describe at least two concepts about why defects occur.

4. Describe the five steps in analyzing a CLABSI as a defect and discuss techniques related to each.

Objectives

Page 4: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

What is a Defect ?

Defect:• Any clinical or operational event or situation that you

would not want to happen again. May include events that you believe actually caused harm or put patients at risk for significant harm.

Johns Hopkins’s “Learning from Defects” tool. Appendix 6 of On the CUSP: Stop BSI toolkit at http://www.onthecuspstophai.org/on-the-cuspstop-bsi/ Accessed 8/24/12

Page 5: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Defect Analysis:-the process of analyzing a defect to determine its root cause.

Defect Prevention:-the process of addressing root causes of defects to prevent their future occurrence.

Lanier K. Experiences In Root Cause Analysis and Defect Prevention Methods. Presentation publically available at http://www.dtic.mil/ndia/2004cmmi/CMMIT5Tue/Root_CauseAnalysis.pdf

Accessed April 2010.

Definitions

Page 6: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

The Five Steps of CUSP

1. Educate on the Science of Safety (7/31/12 webinar)

2. Identify defects (today)

3. Engage leadership (now and future)

4. Continue to learn from defects (today)

5. Teamwork and communication (now and future)

Page 7: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

CUSP Step 2: Identifying Defects

• Through reports – HAI (CLABSI) reports from Infection Prevention and staff, med error reports, incident reports, etc.

• Patient and family feedback• Gemba walks• Unit monitors• Staff feedback, sharing information in a psychologically

friendly environment, asking, “How will the next patient be harmed?”

• Reporting of “near misses”

http://www.onthecuspstophai.org/on-the-cuspstop-bsi/toolkits-and-resources/#cusp

Page 8: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

CUSP Step 4: Learning from Defects

1.What happened?

2.Why did it happen?

3.How will you reduce the likelihood of it happening again?

4.How will you know the risk is reduced?

5.With whom should you share the learning?

Page 9: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Learning from defects:

•Reduces the likelihood of the event reoccurring and causing harm.

•May occur in two important areas:o System designo Human behavior

•Provides structure and consistency.

•Allows learning from common cause and special variations.

•Allows prevention further “upstream” from the untoward outcome (CLABSI) to make care even safer.

It’s All About Prevention

Page 10: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Reimbursement systems are being reengineered to reward the best performers (no margin, no mission, no salary, no job…)

• Growing transparency of outcomes – public reporting

• Defects are expensive in many ways…

• Excellence in care - learning from each defect is the best way to prevent it from reoccurring.

• The Golden Rule-it’s what we’d want done for us or the person we love most!

Why is this Important?

Page 11: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Background Concepts

1. Normalized deviance: • Long-term phenomenon in which individuals or teams

repeatedly accept a lower standard of performance lower standard becomes the “norm.”

• Deviation from SOP becomes routine practice and is “normalized.” becomes acceptable may no longer even be recognized as deviation. (Just Culture

“behavioral drift”, at-risk behavior)

• Allowed because we get away with it…most of the time…

Page 12: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Normalized Deviance in Real Life

• I (Shelby) have three rescue dogs, all my furry children that I love dearly. However, I put one of them, Bindi Sue, in a life-threatening situation one day. I was practicing normalized deviance: any dog owner knows that allowing your dog to ride in a motor vehicle with their head out the window is asking for disaster. I did it because Bindi loved it. One day, we were riding in my SUV with the windows rolled down and when I made a left-hand turn, it pitched Bindi out of the back window into a busy intersection. After a trip to the vet, she was officially deemed OK but I could have easily killed my beloved Bindi.

• Now as you listened to this story, what were you thinking? “Gosh, I’ve done the same thing.” or “How stupid can you be? Didn’t you know better?” or “I remember when I did something like that…” It got you to thinking about situations you may have been in that could have resulted in a pet’s or child’s harm maybe. My telling my story helps others to realize that we all do things we may know are not the best practice. But, we get away with it, most of the time.

Page 13: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Speeding?• Leaving written passwords in clear view around

your computer?• Not getting your dryer vent cleaned routinely?• What are some other things?

What are some deviances you’ve normalized?

Page 14: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Inconsistent hand hygiene practices?• Not disinfecting access ports “swabbing the hub” on IV

when entering for medication administration or not swabbing for at least 15 seconds?

• Not “CUSS’ing” when a provider is not following proper central line insertion bundle protocols or you see a peer breech central line maintenance standards?

• What are some others?

CLABSI “SUV Rides”

Page 15: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• “The rule(s) is stupid”• Rule or reason for it is unknown• New technology• Complexity of work• Rule does not apply to this patient• “Rule(s) doesn’t apply to me”• “I know a better way”• Healthcare worker is not the one at risk• Competing priorities:

o Cost and time,o Culture (politics, hierarchy, lack of communication openness, etc.)

• “It won’t hurt anything this one time…”

Excuses to Deviate

Page 16: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Background Concept 2: Errors in Complex Systems

• When dealing with complex systems, such as healthcare, we have both sharp end and blunt end factors.

• The “sharp end” refers to the personnel or parts of the health care system in direct contact with patients. Personnel operating at the sharp end may literally be holding a scalpel (eg, an orthopedist who operates on the wrong leg) or figuratively be administering any kind of therapy (eg, a nurse inserting a Foley) or performing any aspect of Foley care. This is where active failures can occur.

• The blunt end refers to the background of policies, administrative priorities, process designs, etc. where decisions are made that impact the sharp end “downstream.” This is where latent failures occur and most often where the root cause of an active failure may be found.

Page 17: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Active failures: failures that occur at the point of contact between a human and some aspect of a larger system (e.g., a human-machine interface).

o readily apparent (e.g., pushing an incorrect button, not following sterile technique to change a CL dressing)

o involve someone at the frontline or “sharp end”.

Active Failures

Page 18: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Latent Failures: less apparent failures of organization or system/process design that contribute to the occurrence of errors or allowed them to cause harm to patients.

o Occurrences are at the “blunt end” but may result in active failures on the “sharp end.”

o AKA: “Accidents waiting to happen.”

Reason JT. Human Error. New York, NY: Cambridge University Press; 1990.

Latent Failures

Page 19: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Background Concept 3: Timing of Analysis

Analysis of a defect should occur as soon as possible after the defect is recognized.

The best light is often that from a burning bridge…

~Don Henley

The best learning from a defect occurs before the “light goes out.”

Page 20: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Gemba walk: A Japanese term used in Lean methodology that means, “the real place.” In a business sense, it refers to the place where value is created. o observation where the work is actually carried out, such as on

the nursing unit, learn both what the actual problems are and the best solutions

for those problems.

o activity that takes management to the point of care to find ground truth

• Ground truth: Information that is collected on location and used to compare reality to perception.

Two important terms:

Page 21: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Use some type of standard investigation tool

• Utilize a multidisciplinary team (Unit CUSP Team)

• Investigate details prior to meeting

• Build on Current Process. (“mini-RCA”, a “deep dive” etc.)

• Don’t be afraid to really challenge practice and traditional ways of thinking!

• Environment of psychological safety is critical.

Tips on Learning from each Defect

Page 22: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

1. What happened?

2. Why did it happen?

3. How will you reduce the likelihood of it happening again?

4. How will you know the risk is reduced?

5. With whom should you share the learning?

Basic steps in the “L-from-D” Process

Page 23: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

•44 y.o. female w/ colon CA admitted to your med/surg ICU on

7/12/12 with diarrhea and severe dehydration.

•She is S/P partial colectomy and has a colostomy.

•She was in process of completing her 3rd round of chemotherapy

prior to admission.

•CL inserted 7/12 in Rt. subclavian for hydration and to monitor CVP.

•On 7/19, she became hypothermic w/a temp of 957F and

hypotensive.

•BC Gram stain + for gram negative rods. BCs + for E. coli on 7/20.

•CXR - for pneumonia. Other cultures −.

•CLABSI diagnosis made and antibiotic started.

Case Study

Page 24: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Use a standard event investigation format. (See CLABSI Event Report template as an example).

• Tool should be easy to use.

• No perfect tool so use what works but include information to assess for active and latent errors.

• Must establish a chronological order of events and data related to the event.

• Usually requires some research and gemba walks.

• One person should not do all the research or gemba walks. (Science of Safety principle: Teams make wise decisions when there is diverse and independent input.)

Step 1: What Happened?

Page 25: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Example of an Event Investigation Tool

• Patient: JJ• MR No: 29292999• Admit Date: 7/12/12• Diagnosis:. Colon cancer, receiving 3rd round of chemo, has colonoscopy s/p partial colectomy• Infection Date: 7/19/12• Criteria: Hypotension, hypothermia, +BC Organism: E. coli• CVC Insertion Info• Date CVC Removed: 7/20/12• Insertion Site: Rt subclavian Type of Line: TLC• Was insertion bundle used and were all elements complied with when CVC inserted?• YES__X__ NO_____ If NO, explain: • Who Inserted: Dr. McSwain, intensivist• Patient Information and CVC Care Practices • 1 Patient’s location/room number(s) 3415• 2 Proper hand hygiene was used by all personnel involved in line care for this patient? Yes: _X__(From talking to staff and reviewing HH compliance monitors.) No: ___________ If no, please explain:______________________• 3 Date of last CVC dressing change and skin condition at insertion site at that time: 7/18/12. Site clean and dry per documentation at time of dressing change.• 4 A 2% Chlorhexidine/70% alcohol scrub followed by air dry used during last CVC dressing change and a CHG-impregnated sponge was used.• Yes: _X_ No: _____ •  5 A 70% alcohol swabbing for 15 seconds followed by air dry used prior to accessing the CVC hub/port. Yes: __X per RNs’ verbal report. No: ___ If no, please explain:____________________________• 6 48-72 hours before infection date, who accessed the CVC system (check all that apply)? _X__Unit Nurse ___Nurse from Other Unit ____ Attending MD ____Resident/Fellow ____Anesthesia ___ Radiology Personnel ___ Other

__________________________• 7 Estimated number of CVC system entries for each 24-hour period for 72-hours prior to infection date: 20 times/24 hours on average (medication administration, blood draws, connection of IVF, etc.)• 8 What are compliance rates for “scrubbing the hub” before accessing line, on this unit? Previous monitors last month revealed an 96% compliance in sampling. Education and focus on scrubbing hub has been an ongoing theme.• 9 Date of last IV administration set change(s)

Lipid and/or blood products (q24h) ___N/A______________

All other sets (q72-96h) __7/18/11______ ›• 10 Estimated hang time for parenteral fluid(s) over last 72 hours prior to infection

Lipids (q24h) ___N/A __________

All other fluids __36 hours______________•  11 Central line removal discussed daily? Yes: __X by nurses________

No: ___________ If no, please explain:• 12 Describe any mechanical problems with CVC prior to the infection date

None.

• 13 Have there been any problems with the CVC or IV equipment or supplies?• Yes: _____If Yes, please explain: _____________ No: ____X_______ • 14 Did the person who inserted the catheter have documented competency to insert? Yes: __X – med staff credential granted upon hire________

No: ___________ If no, please explain why:_______________________• 15 What is hand hygiene compliance like for all units patient was in where pt had a CVC? HH compliance rate for this unit at 98% avg for past 3 months• 16 How did workload/unit activity impact insertion and care of the CVC?• Census running consistently at 90% for past two months and unit has had 3 resignations. RNs from staffing pool are used for at least 3 shifts per week.now.• 17 Can each staff member involved in this patient’s care verbalize correct strategies to prevent CLABSI? Yes: ___X_____Pool nurses are specific for ICU and get the same orientation to CLABSI and HAI prevention in the unit as do full time ICU staff. No:

_ ___ • 18 Are there any significant patient factors that may have contributed to this infection? Pt. on chemotherapy and WBC 2 on arrival to the hospital. Immunocompromised. Pt also having severe diarrhea secondary to ? • 19 After your assessment, do you believe this infection was potentially preventable? Yes: _____ Please explain why:

No: ___X_____ Please explain why: Pt severely immunocompromised• If defect(s) identified, use the Learning from Defects Tool to prevent future defect(s).

Page 26: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

1. E. coli grown in blood from BC done 7 days after admission and 7 days after CL was inserted.

2. Patient was immunocompromised with leukopenia (WBC 2 on adm.)

3. Patient was having severe diarrhea

4. Pool nurse staffing used more than desired

What have we learned from Event Report Tool?

Page 27: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Additional information needed:•How is environmental room cleaning done? How often?•What is our patient hygiene like, including hand hygiene?•What is compliance to “scrub the hub” since the educational push? Has it fallen off?•What is our true hand hygiene compliance rate?•How was the diarrhea managed?

Step 1: Example

Page 28: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Additional Learning…

• Direct patient-contact environmental surfaces are not cleaned in occupied beds by EVS.

• Unit staff use bath basins to give bed baths; they rinse basins after use and allow to dry. UM saw one pool RN giving a bath from the sink during one gemba. UM did a lit review on IPH.

• Diarrhea management was difficult w/many spills onto bed and patient. No WOCN on staff at hospital to help. They used the largest colostomy bags the hospital stocked.

• UM enlisted a hospital volunteer to do “secret shopping” observations w/hand hygiene and scrub the hub X 1 wk. He found HH at 52% and scrub the hub at 80%. (HH % driven by non-nurses)

Page 29: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

1. Review events from event report with unit CUSP team2. Identify any gaps3. For each gap identified, ask “Why?” and then for each reason

generated, ask “Why?” at least four more times or until the group feels the root cause has been found. (Keep pushing to the 5 “Whys” to ensure root cause is determined and latent failures are recognized if present.)

Further research/lit review may be necessary to gather ground truth, determine why it happened, and if there were any gaps with best practice. This is another time when gemba walks, staff and/or patient interviews, and literature reviews may be indicated.

Step 2: Why Did It Happen?

Page 30: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Step 2: The 5 Why’s – an Example

Gap: Direct patient-contact environmental surfaces are not cleaned in occupied beds. 1.Why? EVS policy prohibits.

2.Why? Risk of cleaning chemicals causing respiratory and/or topical issues with patients.

3.Why? Direct or close contact w/hospital-grade chemicals can be toxic and patients are already compromised.

4.Why? There are no physical or spatial barriers between the patient and the surface disinfectants currently used.

5.Why? Not possible, given the physical proximity. Would need to protect the patient’s entire body and airway.

6.Why? Spray disinfectants are currently the primary type used and thus are not usable in close proximity to the patient.

Page 31: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

1. Prioritize most important contributing factors.

2. Develop interventions (countermeasures) to defend against the most important contributing factors.

3. Then, rate each countermeasure on its ability to mitigate the root cause and on the team’s belief that the countermeasure will be executed.

4. Make an action plan for 2-5 of the highest scoring countermeasure.

• Must have many different perspectives.• Must engage leadership.

Step 3: How can we reduce the chances of it happening again?

Page 32: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Example: Prioritize contributing factors

Contributing FactorsImportance to current event, 1 (low) to 5 (high)

Importance to future events 1 (low) to 5 (high)

Ease of Resolution 3 =easy, 2 = fairly easy1=hard

Total Score

High bioburden of colonic organisms on environmental surfaces directly in contact w/patient due to no cleaning of these surfaces done in occupied beds.

5 5 1 11

High bioburden of colonic organisms on environmental surfaces directly in contact w/patient due to inadequate diarrhea management processes.

5 2 2 9

Inadequate patient hygiene practices due to lack of knowledge of current science.

5 5 2 12

Swabbing of CL hubs prior to use is inconsistent due to perceived time pressures from lack of staffing

5 5 2 12

Hand hygiene compliance inadequate, especially in non-unit staff, due to ?

5 5 2 12

Page 33: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Consider safe design principles:• Standardize – eliminate steps when possible• Create independent checklists• Learn when things go wrong (analyze defects)

• Safe designs apply to technical and team work.• Brainstorm strategies and consider:

1.Ability to mitigate error.

2.Strength of countermeasures to prevent error.

3.Ease of implementation. (Resources and will necessary to implement.)

Countermeasures

Page 34: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Rank Order: Strength of Error Reduction Strategies

Page 35: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Countermeasures (interventions to reduce the risk of the defect) to Prevent Inadequate Patient Hygiene.

Ability to mitigate the contributing factor, 1 (low) to 5 (high)

Team believes the countermeasure will be implemented and executed, 1 (low) to 5 (high)

Strength of Strategy, 1 (low) to 7 (high)

Total Score

A. Provide mandatory education to staff on Interventional Patient Hygiene in the ICU.

4 5 2 11

B. Implement protocol for patient hand hygiene before and after meals and after every use of bathroom/urinal/bedpan/BM. (Pt education and posted reminders in room.)

4 4 5 13

C. Revise patient bathing protocol to require disinfection of bath basins after each bath.

4 3 5 12

D. Revise patient bathing protocol to forbid using sink as a bath basin.

2 5 5 12

E. Revise patient bathing protocol to include CHG-impregnated bathing on a daily basis in the ICU.

5 3 5 13

F. Educate visitors about importance of hand hygiene and have them perform hand hygiene before entering pt’s room and before & after physical contact.

3 3 2 8

Page 36: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Assess outcome and process data (CLABSI rates, compliance to CL maintenance protocols, monitoring of specific process changes, etc.)

• Talk to staff to get their perspectives.• Talk to patients/families to get their

perspectives.• Do gemba walks for direct observation.• Feedback from patient safety rounds.

Step 4: How will we know the risk is reduced?

Page 37: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Internal communications– other areas/people possibly prone to this defect.– what other people/groups need to know for the purposes of

regulatory compliance, accreditation concerns, risk management.– what people/groups need to know for closure on the event.– what other potential defects could occur related to root causes

identified

• External communications– PSOs– Others– Must include input/permission from Risk Management and

Administration

Step 5: How do we communicate our findings and to whom?

Page 38: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Can help prevent future errors and prevent human suffering and death.

• Needs consistent discipline through structured way of thinking and communicating.

• Highest form of learning is from and by the group “Teams make wise decisions when there is diverse and independent input.”

• Purpose of Defects Analysis is to help drive constructive, open communication.

Remember: Learning from Defects

Page 39: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Thank You

39

Questions?

Page 40: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

How well did this Learning activity meet the stated objectives?

1.Excellent

2.Good

3.Fair

4.Poor

5.N/A

Polling Question #1

40

1.Describe how defect analysis is a foundational element of CUSP.

2.Define “defect.”

3.Describe at least two concepts about why defects occur.

4.Describe the five steps in analyzing a CLABSI as a defect and discuss techniques related to each.

Page 41: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Amount of useful information and ideas provided: Excellent

1.Excellent

2.Good

3.Fair

4.Poor

5.N/A

Polling Question #2

41

Page 42: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Usefulness to my hospital of the information and ideas provided:

Polling Question #3

1. Excellent

2. Good

3. Fair

4. Poor

5. N/A

42

Page 43: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Chance that the information and ideas provided will improve my effectiveness and results:

Polling Question #4

43

Page 44: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

TimelineSafety Culture Survey Safety Culture Survey (baseline)(baseline)

September 15, 2012September 15, 2012

Action Periods June 2012 – December 2013

Data CollectionData CollectionRefer to data schedule for details

Baseline: Jan-June 2012Baseline: Jan-June 2012Begin Monthly July 2012Begin Monthly July 2012

3 Monthly Orientation Webinars

June 19: MeasurementJuly 31: Science of SafetyAug 28: Learning from DefectsAug 28: Learning from Defects

Upcoming WebinarsUpcoming Webinars Success StoriesSuccess StoriesCulture of Safety Survey ResultsCulture of Safety Survey Results

Quarterly Content Webinars Beginning December 2012

Learning Session 2 January 30, 2013

44

Page 45: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

• Complete AHRQ HSOPS Culture of Safety survey on selected unit(s) by September 15

• Grant NSHN group rights to NCQC or enter baseline CLABSI rate data into QDS (Jan-June 2012)

• Begin Data Collection on CL review for necessityo Enter into QDS

• Conduct Defects Analysis for any CLABSI events on unit• Upcoming Webinarso Hospital Success Storieso Culture of Safety Survey Results

Next Steps(September-October)

Page 46: Jan Mangun, MT(ASCP), MSA, CPHRM Executive Director, Quality and Patient Safety

Contact Information

Jan Mangun, MT(ASCP), MSA, CPHRM

Executive Directive, Quality & Patient Safety

[email protected]

804-965-1202

Debbie Roddenberry

Assistant Director

[email protected]

804-965-5714